Eisler Capital (US)’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$673K Buy
+23,267
New +$679K 0.01% 410
2023
Q4
Sell
-68,468
Closed -$2.07M 379
2023
Q3
$2.27M Buy
68,468
+24,400
+55% +$863K 0.06% 217
2023
Q2
$1.62M Buy
44,068
+19,000
+76% +$740K 0.06% 213
2023
Q1
$1.02M Buy
+25,068
New +$1.08M 0.08% 156

Other funds holding PFE

Eisler Capital (US)'s PFE Position: Q3 2024 in Review

Eisler Capital (US) opened a new position in Pfizer (PFE) in Q3 2024: 23,267 shares worth $673K. The stake represents 0.01% of the portfolio and ranks #410 among its holdings. This is a return to the name: Eisler Capital (US) previously reported a position in PFE as recently as Q3 2023.

Eisler Capital (US) first reported a position in PFE in Q1 2023 and has held it in 4 quarters since. The position peaked at $2.27M in Q3 2023. 2,911 funds tracked by Wall St. Rank hold PFE as of Q3 2024.

  • Eisler Capital (US) held 23,267 shares of Pfizer worth $673K as of Q3 2024.
  • Pfizer was a new Eisler Capital (US) position in Q3 2024.
  • Pfizer made up 0.01% of Eisler Capital (US)'s portfolio in Q3 2024, its #410 holding.
  • Eisler Capital (US) first reported a position in Pfizer in Q1 2023 and has held it in 4 quarters since.
  • Eisler Capital (US)'s Pfizer position peaked at $2.27M in Q3 2023.
  • 2,911 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.

Based on Eisler Capital (US)'s 13F filing for Q3 2024, filed 14 Nov 2024.